Related Articles
AGR3 promotes estrogen receptor‑positive breast cancer cell proliferation in an estrogen‑dependent manner
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape
AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation
RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation
β‑elemene inhibits non‑small cell lung cancer cell migration and invasion by inactivating the FAK‑Src pathway